nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—urinary bladder cancer	0.533	1	CbGaD
Desmopressin—PTGS2—Cisplatin—urinary bladder cancer	0.0664	0.356	CbGbCtD
Desmopressin—PTGS2—Etoposide—urinary bladder cancer	0.0652	0.349	CbGbCtD
Desmopressin—PTGS1—Etoposide—urinary bladder cancer	0.0551	0.295	CbGbCtD
Desmopressin—AVPR2—urine—urinary bladder cancer	0.0245	0.508	CbGeAlD
Desmopressin—AVPR2—renal system—urinary bladder cancer	0.00599	0.124	CbGeAlD
Desmopressin—PTGS1—prostate gland—urinary bladder cancer	0.0016	0.0332	CbGeAlD
Desmopressin—PTGS2—prostate gland—urinary bladder cancer	0.00153	0.0318	CbGeAlD
Desmopressin—Octreotide—MPO—urinary bladder cancer	0.00137	1	CrCbGaD
Desmopressin—PTGS1—seminal vesicle—urinary bladder cancer	0.00135	0.0281	CbGeAlD
Desmopressin—PTGS2—seminal vesicle—urinary bladder cancer	0.0013	0.0269	CbGeAlD
Desmopressin—PTGS1—epithelium—urinary bladder cancer	0.00118	0.0244	CbGeAlD
Desmopressin—PTGS1—smooth muscle tissue—urinary bladder cancer	0.00113	0.0235	CbGeAlD
Desmopressin—PTGS2—epithelium—urinary bladder cancer	0.00113	0.0233	CbGeAlD
Desmopressin—PTGS1—renal system—urinary bladder cancer	0.00109	0.0227	CbGeAlD
Desmopressin—PTGS2—smooth muscle tissue—urinary bladder cancer	0.00108	0.0225	CbGeAlD
Desmopressin—PTGS2—renal system—urinary bladder cancer	0.00104	0.0217	CbGeAlD
Desmopressin—PTGS2—urethra—urinary bladder cancer	0.00103	0.0213	CbGeAlD
Desmopressin—PTGS1—female reproductive system—urinary bladder cancer	0.000874	0.0181	CbGeAlD
Desmopressin—PTGS2—female reproductive system—urinary bladder cancer	0.000836	0.0173	CbGeAlD
Desmopressin—PTGS1—vagina—urinary bladder cancer	0.000791	0.0164	CbGeAlD
Desmopressin—PTGS2—vagina—urinary bladder cancer	0.000756	0.0157	CbGeAlD
Desmopressin—PTGS1—lymph node—urinary bladder cancer	0.000512	0.0106	CbGeAlD
Desmopressin—PTGS2—lymph node—urinary bladder cancer	0.000489	0.0101	CbGeAlD
Desmopressin—Headache—Thiotepa—urinary bladder cancer	0.00022	0.00116	CcSEcCtD
Desmopressin—Decreased appetite—Etoposide—urinary bladder cancer	0.00022	0.00115	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000218	0.00114	CcSEcCtD
Desmopressin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000218	0.00114	CcSEcCtD
Desmopressin—Fatigue—Etoposide—urinary bladder cancer	0.000218	0.00114	CcSEcCtD
Desmopressin—Pain—Etoposide—urinary bladder cancer	0.000216	0.00113	CcSEcCtD
Desmopressin—Constipation—Etoposide—urinary bladder cancer	0.000216	0.00113	CcSEcCtD
Desmopressin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000216	0.00113	CcSEcCtD
Desmopressin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000214	0.00113	CcSEcCtD
Desmopressin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000214	0.00112	CcSEcCtD
Desmopressin—Sweating—Epirubicin—urinary bladder cancer	0.000213	0.00112	CcSEcCtD
Desmopressin—Asthenia—Gemcitabine—urinary bladder cancer	0.000212	0.00111	CcSEcCtD
Desmopressin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.00021	0.0011	CcSEcCtD
Desmopressin—Weight increased—Doxorubicin—urinary bladder cancer	0.00021	0.0011	CcSEcCtD
Desmopressin—Epistaxis—Epirubicin—urinary bladder cancer	0.00021	0.0011	CcSEcCtD
Desmopressin—Pruritus—Gemcitabine—urinary bladder cancer	0.000209	0.0011	CcSEcCtD
Desmopressin—Nausea—Thiotepa—urinary bladder cancer	0.000209	0.0011	CcSEcCtD
Desmopressin—Urethral disorder—Methotrexate—urinary bladder cancer	0.000209	0.0011	CcSEcCtD
Desmopressin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000208	0.00109	CcSEcCtD
Desmopressin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000207	0.00108	CcSEcCtD
Desmopressin—Pruritus—Fluorouracil—urinary bladder cancer	0.000206	0.00108	CcSEcCtD
Desmopressin—Visual impairment—Methotrexate—urinary bladder cancer	0.000205	0.00108	CcSEcCtD
Desmopressin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000203	0.00107	CcSEcCtD
Desmopressin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000203	0.00106	CcSEcCtD
Desmopressin—Urticaria—Etoposide—urinary bladder cancer	0.000201	0.00105	CcSEcCtD
Desmopressin—Rhinitis—Epirubicin—urinary bladder cancer	0.0002	0.00105	CcSEcCtD
Desmopressin—Body temperature increased—Etoposide—urinary bladder cancer	0.0002	0.00105	CcSEcCtD
Desmopressin—Abdominal pain—Etoposide—urinary bladder cancer	0.0002	0.00105	CcSEcCtD
Desmopressin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.0002	0.00105	CcSEcCtD
Desmopressin—Eye disorder—Methotrexate—urinary bladder cancer	0.000199	0.00104	CcSEcCtD
Desmopressin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000199	0.00104	CcSEcCtD
Desmopressin—Asthenia—Cisplatin—urinary bladder cancer	0.000198	0.00104	CcSEcCtD
Desmopressin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000198	0.00104	CcSEcCtD
Desmopressin—Sweating—Doxorubicin—urinary bladder cancer	0.000197	0.00103	CcSEcCtD
Desmopressin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000197	0.00103	CcSEcCtD
Desmopressin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000196	0.00103	CcSEcCtD
Desmopressin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000196	0.00103	CcSEcCtD
Desmopressin—Urethral disorder—Epirubicin—urinary bladder cancer	0.000195	0.00103	CcSEcCtD
Desmopressin—Epistaxis—Doxorubicin—urinary bladder cancer	0.000194	0.00102	CcSEcCtD
Desmopressin—Angiopathy—Methotrexate—urinary bladder cancer	0.000193	0.00101	CcSEcCtD
Desmopressin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000192	0.00101	CcSEcCtD
Desmopressin—Dizziness—Fluorouracil—urinary bladder cancer	0.000192	0.00101	CcSEcCtD
Desmopressin—Visual impairment—Epirubicin—urinary bladder cancer	0.000192	0.00101	CcSEcCtD
Desmopressin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000192	0.00101	CcSEcCtD
Desmopressin—Chills—Methotrexate—urinary bladder cancer	0.000191	0.001	CcSEcCtD
Desmopressin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000189	0.00099	CcSEcCtD
Desmopressin—Vomiting—Gemcitabine—urinary bladder cancer	0.000188	0.000987	CcSEcCtD
Desmopressin—Mental disorder—Methotrexate—urinary bladder cancer	0.000187	0.00098	CcSEcCtD
Desmopressin—Rash—Gemcitabine—urinary bladder cancer	0.000187	0.000979	CcSEcCtD
Desmopressin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000186	0.000978	CcSEcCtD
Desmopressin—Eye disorder—Epirubicin—urinary bladder cancer	0.000186	0.000978	CcSEcCtD
Desmopressin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000186	0.000977	CcSEcCtD
Desmopressin—Malnutrition—Methotrexate—urinary bladder cancer	0.000185	0.000973	CcSEcCtD
Desmopressin—Erythema—Methotrexate—urinary bladder cancer	0.000185	0.000973	CcSEcCtD
Desmopressin—Headache—Gemcitabine—urinary bladder cancer	0.000185	0.000973	CcSEcCtD
Desmopressin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000185	0.000971	CcSEcCtD
Desmopressin—Flushing—Epirubicin—urinary bladder cancer	0.000185	0.000971	CcSEcCtD
Desmopressin—Vomiting—Fluorouracil—urinary bladder cancer	0.000185	0.000971	CcSEcCtD
Desmopressin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000185	0.000971	CcSEcCtD
Desmopressin—Rash—Fluorouracil—urinary bladder cancer	0.000183	0.000963	CcSEcCtD
Desmopressin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000183	0.000962	CcSEcCtD
Desmopressin—Headache—Fluorouracil—urinary bladder cancer	0.000182	0.000957	CcSEcCtD
Desmopressin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000182	0.000956	CcSEcCtD
Desmopressin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000182	0.000954	CcSEcCtD
Desmopressin—Asthenia—Etoposide—urinary bladder cancer	0.000181	0.000952	CcSEcCtD
Desmopressin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000181	0.000951	CcSEcCtD
Desmopressin—Angiopathy—Epirubicin—urinary bladder cancer	0.000181	0.000949	CcSEcCtD
Desmopressin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000181	0.000949	CcSEcCtD
Desmopressin—Immune system disorder—Epirubicin—urinary bladder cancer	0.00018	0.000945	CcSEcCtD
Desmopressin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00018	0.000943	CcSEcCtD
Desmopressin—Chills—Epirubicin—urinary bladder cancer	0.000179	0.000939	CcSEcCtD
Desmopressin—Pruritus—Etoposide—urinary bladder cancer	0.000179	0.000938	CcSEcCtD
Desmopressin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000178	0.000933	CcSEcCtD
Desmopressin—Nausea—Gemcitabine—urinary bladder cancer	0.000176	0.000923	CcSEcCtD
Desmopressin—Vomiting—Cisplatin—urinary bladder cancer	0.000175	0.00092	CcSEcCtD
Desmopressin—Mental disorder—Epirubicin—urinary bladder cancer	0.000175	0.000917	CcSEcCtD
Desmopressin—Rash—Cisplatin—urinary bladder cancer	0.000174	0.000913	CcSEcCtD
Desmopressin—Dermatitis—Cisplatin—urinary bladder cancer	0.000174	0.000912	CcSEcCtD
Desmopressin—Erythema—Epirubicin—urinary bladder cancer	0.000174	0.000911	CcSEcCtD
Desmopressin—Malnutrition—Epirubicin—urinary bladder cancer	0.000174	0.000911	CcSEcCtD
Desmopressin—Diarrhoea—Etoposide—urinary bladder cancer	0.000173	0.000907	CcSEcCtD
Desmopressin—Nausea—Fluorouracil—urinary bladder cancer	0.000173	0.000907	CcSEcCtD
Desmopressin—Eye disorder—Doxorubicin—urinary bladder cancer	0.000172	0.000905	CcSEcCtD
Desmopressin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000172	0.000903	CcSEcCtD
Desmopressin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000171	0.000899	CcSEcCtD
Desmopressin—Flushing—Doxorubicin—urinary bladder cancer	0.000171	0.000899	CcSEcCtD
Desmopressin—Flatulence—Epirubicin—urinary bladder cancer	0.000171	0.000898	CcSEcCtD
Desmopressin—Tension—Epirubicin—urinary bladder cancer	0.00017	0.000894	CcSEcCtD
Desmopressin—Nervousness—Epirubicin—urinary bladder cancer	0.000169	0.000885	CcSEcCtD
Desmopressin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000167	0.000878	CcSEcCtD
Desmopressin—Malaise—Methotrexate—urinary bladder cancer	0.000167	0.000878	CcSEcCtD
Desmopressin—Dizziness—Etoposide—urinary bladder cancer	0.000167	0.000877	CcSEcCtD
Desmopressin—Muscle spasms—Epirubicin—urinary bladder cancer	0.000167	0.000876	CcSEcCtD
Desmopressin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000167	0.000875	CcSEcCtD
Desmopressin—Vertigo—Methotrexate—urinary bladder cancer	0.000167	0.000874	CcSEcCtD
Desmopressin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000166	0.000873	CcSEcCtD
Desmopressin—Chills—Doxorubicin—urinary bladder cancer	0.000166	0.000869	CcSEcCtD
Desmopressin—Nausea—Cisplatin—urinary bladder cancer	0.000164	0.00086	CcSEcCtD
Desmopressin—Cough—Methotrexate—urinary bladder cancer	0.000162	0.000849	CcSEcCtD
Desmopressin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000162	0.000848	CcSEcCtD
Desmopressin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000161	0.000845	CcSEcCtD
Desmopressin—Convulsion—Methotrexate—urinary bladder cancer	0.000161	0.000843	CcSEcCtD
Desmopressin—Vomiting—Etoposide—urinary bladder cancer	0.000161	0.000843	CcSEcCtD
Desmopressin—Erythema—Doxorubicin—urinary bladder cancer	0.000161	0.000843	CcSEcCtD
Desmopressin—Malnutrition—Doxorubicin—urinary bladder cancer	0.000161	0.000843	CcSEcCtD
Desmopressin—Agitation—Epirubicin—urinary bladder cancer	0.00016	0.000837	CcSEcCtD
Desmopressin—Rash—Etoposide—urinary bladder cancer	0.000159	0.000836	CcSEcCtD
Desmopressin—Dermatitis—Etoposide—urinary bladder cancer	0.000159	0.000835	CcSEcCtD
Desmopressin—Headache—Etoposide—urinary bladder cancer	0.000158	0.000831	CcSEcCtD
Desmopressin—Flatulence—Doxorubicin—urinary bladder cancer	0.000158	0.000831	CcSEcCtD
Desmopressin—Myalgia—Methotrexate—urinary bladder cancer	0.000158	0.000829	CcSEcCtD
Desmopressin—Chest pain—Methotrexate—urinary bladder cancer	0.000158	0.000829	CcSEcCtD
Desmopressin—Tension—Doxorubicin—urinary bladder cancer	0.000158	0.000827	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000157	0.000823	CcSEcCtD
Desmopressin—Malaise—Epirubicin—urinary bladder cancer	0.000157	0.000821	CcSEcCtD
Desmopressin—Discomfort—Methotrexate—urinary bladder cancer	0.000156	0.000819	CcSEcCtD
Desmopressin—Nervousness—Doxorubicin—urinary bladder cancer	0.000156	0.000819	CcSEcCtD
Desmopressin—Vertigo—Epirubicin—urinary bladder cancer	0.000156	0.000818	CcSEcCtD
Desmopressin—Syncope—Epirubicin—urinary bladder cancer	0.000156	0.000817	CcSEcCtD
Desmopressin—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000154	0.00081	CcSEcCtD
Desmopressin—Palpitations—Epirubicin—urinary bladder cancer	0.000153	0.000805	CcSEcCtD
Desmopressin—Confusional state—Methotrexate—urinary bladder cancer	0.000153	0.000801	CcSEcCtD
Desmopressin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000153	0.000801	CcSEcCtD
Desmopressin—Cough—Epirubicin—urinary bladder cancer	0.000151	0.000795	CcSEcCtD
Desmopressin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000151	0.000794	CcSEcCtD
Desmopressin—Convulsion—Epirubicin—urinary bladder cancer	0.00015	0.000789	CcSEcCtD
Desmopressin—Infection—Methotrexate—urinary bladder cancer	0.00015	0.000789	CcSEcCtD
Desmopressin—Nausea—Etoposide—urinary bladder cancer	0.00015	0.000788	CcSEcCtD
Desmopressin—Hypertension—Epirubicin—urinary bladder cancer	0.00015	0.000786	CcSEcCtD
Desmopressin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000149	0.000782	CcSEcCtD
Desmopressin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000148	0.000779	CcSEcCtD
Desmopressin—Myalgia—Epirubicin—urinary bladder cancer	0.000148	0.000775	CcSEcCtD
Desmopressin—Chest pain—Epirubicin—urinary bladder cancer	0.000148	0.000775	CcSEcCtD
Desmopressin—Agitation—Doxorubicin—urinary bladder cancer	0.000148	0.000775	CcSEcCtD
Desmopressin—Anxiety—Epirubicin—urinary bladder cancer	0.000147	0.000773	CcSEcCtD
Desmopressin—Skin disorder—Methotrexate—urinary bladder cancer	0.000147	0.000772	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000147	0.00077	CcSEcCtD
Desmopressin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000146	0.000768	CcSEcCtD
Desmopressin—Discomfort—Epirubicin—urinary bladder cancer	0.000146	0.000766	CcSEcCtD
Desmopressin—Malaise—Doxorubicin—urinary bladder cancer	0.000145	0.00076	CcSEcCtD
Desmopressin—Vertigo—Doxorubicin—urinary bladder cancer	0.000144	0.000757	CcSEcCtD
Desmopressin—Anorexia—Methotrexate—urinary bladder cancer	0.000144	0.000757	CcSEcCtD
Desmopressin—Syncope—Doxorubicin—urinary bladder cancer	0.000144	0.000756	CcSEcCtD
Desmopressin—Confusional state—Epirubicin—urinary bladder cancer	0.000143	0.00075	CcSEcCtD
Desmopressin—Palpitations—Doxorubicin—urinary bladder cancer	0.000142	0.000745	CcSEcCtD
Desmopressin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000142	0.000743	CcSEcCtD
Desmopressin—Oedema—Epirubicin—urinary bladder cancer	0.000142	0.000743	CcSEcCtD
Desmopressin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000141	0.000741	CcSEcCtD
Desmopressin—Infection—Epirubicin—urinary bladder cancer	0.000141	0.000739	CcSEcCtD
Desmopressin—Cough—Doxorubicin—urinary bladder cancer	0.00014	0.000735	CcSEcCtD
Desmopressin—Shock—Epirubicin—urinary bladder cancer	0.000139	0.000731	CcSEcCtD
Desmopressin—Convulsion—Doxorubicin—urinary bladder cancer	0.000139	0.00073	CcSEcCtD
Desmopressin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000139	0.000729	CcSEcCtD
Desmopressin—Hypertension—Doxorubicin—urinary bladder cancer	0.000139	0.000728	CcSEcCtD
Desmopressin—Tachycardia—Epirubicin—urinary bladder cancer	0.000138	0.000726	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000138	0.000724	CcSEcCtD
Desmopressin—Skin disorder—Epirubicin—urinary bladder cancer	0.000138	0.000722	CcSEcCtD
Desmopressin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000137	0.000719	CcSEcCtD
Desmopressin—Insomnia—Methotrexate—urinary bladder cancer	0.000137	0.000718	CcSEcCtD
Desmopressin—Myalgia—Doxorubicin—urinary bladder cancer	0.000137	0.000718	CcSEcCtD
Desmopressin—Chest pain—Doxorubicin—urinary bladder cancer	0.000137	0.000718	CcSEcCtD
Desmopressin—Anxiety—Doxorubicin—urinary bladder cancer	0.000136	0.000715	CcSEcCtD
Desmopressin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000136	0.000713	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000136	0.000713	CcSEcCtD
Desmopressin—Discomfort—Doxorubicin—urinary bladder cancer	0.000135	0.000709	CcSEcCtD
Desmopressin—Anorexia—Epirubicin—urinary bladder cancer	0.000135	0.000709	CcSEcCtD
Desmopressin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000135	0.000708	CcSEcCtD
Desmopressin—Somnolence—Methotrexate—urinary bladder cancer	0.000135	0.000706	CcSEcCtD
Desmopressin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000133	0.000699	CcSEcCtD
Desmopressin—Confusional state—Doxorubicin—urinary bladder cancer	0.000132	0.000694	CcSEcCtD
Desmopressin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000132	0.000691	CcSEcCtD
Desmopressin—Oedema—Doxorubicin—urinary bladder cancer	0.000131	0.000688	CcSEcCtD
Desmopressin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000131	0.000688	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000131	0.000686	CcSEcCtD
Desmopressin—Fatigue—Methotrexate—urinary bladder cancer	0.000131	0.000685	CcSEcCtD
Desmopressin—Infection—Doxorubicin—urinary bladder cancer	0.00013	0.000683	CcSEcCtD
Desmopressin—Pain—Methotrexate—urinary bladder cancer	0.000129	0.000679	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000129	0.000677	CcSEcCtD
Desmopressin—Shock—Doxorubicin—urinary bladder cancer	0.000129	0.000677	CcSEcCtD
Desmopressin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000129	0.000675	CcSEcCtD
Desmopressin—Insomnia—Epirubicin—urinary bladder cancer	0.000128	0.000672	CcSEcCtD
Desmopressin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000128	0.000671	CcSEcCtD
Desmopressin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000668	CcSEcCtD
Desmopressin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000127	0.000668	CcSEcCtD
Desmopressin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000127	0.000665	CcSEcCtD
Desmopressin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000126	0.000663	CcSEcCtD
Desmopressin—Somnolence—Epirubicin—urinary bladder cancer	0.000126	0.000661	CcSEcCtD
Desmopressin—Anorexia—Doxorubicin—urinary bladder cancer	0.000125	0.000656	CcSEcCtD
Desmopressin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000125	0.000655	CcSEcCtD
Desmopressin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000125	0.000654	CcSEcCtD
Desmopressin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000124	0.00065	CcSEcCtD
Desmopressin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000123	0.000646	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000122	0.000642	CcSEcCtD
Desmopressin—Fatigue—Epirubicin—urinary bladder cancer	0.000122	0.000641	CcSEcCtD
Desmopressin—Constipation—Epirubicin—urinary bladder cancer	0.000121	0.000636	CcSEcCtD
Desmopressin—Pain—Epirubicin—urinary bladder cancer	0.000121	0.000636	CcSEcCtD
Desmopressin—Urticaria—Methotrexate—urinary bladder cancer	0.00012	0.000631	CcSEcCtD
Desmopressin—Body temperature increased—Methotrexate—urinary bladder cancer	0.00012	0.000628	CcSEcCtD
Desmopressin—Abdominal pain—Methotrexate—urinary bladder cancer	0.00012	0.000628	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000119	0.000627	CcSEcCtD
Desmopressin—Insomnia—Doxorubicin—urinary bladder cancer	0.000119	0.000622	CcSEcCtD
Desmopressin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000118	0.000618	CcSEcCtD
Desmopressin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000117	0.000613	CcSEcCtD
Desmopressin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000117	0.000613	CcSEcCtD
Desmopressin—Somnolence—Doxorubicin—urinary bladder cancer	0.000117	0.000612	CcSEcCtD
Desmopressin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000116	0.000608	CcSEcCtD
Desmopressin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000115	0.000605	CcSEcCtD
Desmopressin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000114	0.000598	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000113	0.000594	CcSEcCtD
Desmopressin—Fatigue—Doxorubicin—urinary bladder cancer	0.000113	0.000593	CcSEcCtD
Desmopressin—Urticaria—Epirubicin—urinary bladder cancer	0.000113	0.000591	CcSEcCtD
Desmopressin—Constipation—Doxorubicin—urinary bladder cancer	0.000112	0.000588	CcSEcCtD
Desmopressin—Pain—Doxorubicin—urinary bladder cancer	0.000112	0.000588	CcSEcCtD
Desmopressin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000112	0.000588	CcSEcCtD
Desmopressin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000112	0.000588	CcSEcCtD
Desmopressin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000112	0.000585	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000112	0.00275	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CREBBP—urinary bladder cancer	0.000109	0.00268	CbGpPWpGaD
Desmopressin—Asthenia—Methotrexate—urinary bladder cancer	0.000109	0.00057	CcSEcCtD
Desmopressin—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000108	0.00266	CbGpPWpGaD
Desmopressin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000108	0.000567	CcSEcCtD
Desmopressin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000107	0.000562	CcSEcCtD
Desmopressin—Pruritus—Methotrexate—urinary bladder cancer	0.000107	0.000562	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—GLI1—urinary bladder cancer	0.000107	0.00263	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000107	0.00263	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GLI1—urinary bladder cancer	0.000106	0.00261	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000106	0.00261	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—RBX1—urinary bladder cancer	0.000106	0.0026	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.000105	0.00259	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000104	0.00257	CbGpPWpGaD
Desmopressin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000104	0.000548	CcSEcCtD
Desmopressin—Urticaria—Doxorubicin—urinary bladder cancer	0.000104	0.000546	CcSEcCtD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000104	0.00256	CbGpPWpGaD
Desmopressin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000104	0.000544	CcSEcCtD
Desmopressin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000104	0.000544	CcSEcCtD
Desmopressin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000104	0.000544	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000102	0.00251	CbGpPWpGaD
Desmopressin—Asthenia—Epirubicin—urinary bladder cancer	0.000102	0.000533	CcSEcCtD
Desmopressin—Pruritus—Epirubicin—urinary bladder cancer	0.0001	0.000526	CcSEcCtD
Desmopressin—Dizziness—Methotrexate—urinary bladder cancer	0.0001	0.000525	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—TSC1—urinary bladder cancer	9.93e-05	0.00244	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.73e-05	0.00239	CbGpPWpGaD
Desmopressin—Diarrhoea—Epirubicin—urinary bladder cancer	9.69e-05	0.000509	CcSEcCtD
Desmopressin—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.66e-05	0.000507	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.65e-05	0.00238	CbGpPWpGaD
Desmopressin—Vomiting—Methotrexate—urinary bladder cancer	9.63e-05	0.000505	CcSEcCtD
Desmopressin—Rash—Methotrexate—urinary bladder cancer	9.55e-05	0.000501	CcSEcCtD
Desmopressin—Dermatitis—Methotrexate—urinary bladder cancer	9.54e-05	0.0005	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN2A—urinary bladder cancer	9.52e-05	0.00234	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	9.49e-05	0.00234	CbGpPWpGaD
Desmopressin—Headache—Methotrexate—urinary bladder cancer	9.48e-05	0.000498	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—JAG1—urinary bladder cancer	9.45e-05	0.00233	CbGpPWpGaD
Desmopressin—Asthenia—Doxorubicin—urinary bladder cancer	9.41e-05	0.000494	CcSEcCtD
Desmopressin—Dizziness—Epirubicin—urinary bladder cancer	9.37e-05	0.000492	CcSEcCtD
Desmopressin—Pruritus—Doxorubicin—urinary bladder cancer	9.27e-05	0.000487	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	9.1e-05	0.00224	CbGpPWpGaD
Desmopressin—Vomiting—Epirubicin—urinary bladder cancer	9.01e-05	0.000473	CcSEcCtD
Desmopressin—Nausea—Methotrexate—urinary bladder cancer	8.99e-05	0.000472	CcSEcCtD
Desmopressin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.97e-05	0.000471	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	8.96e-05	0.0022	CbGpPWpGaD
Desmopressin—Rash—Epirubicin—urinary bladder cancer	8.93e-05	0.000469	CcSEcCtD
Desmopressin—Dermatitis—Epirubicin—urinary bladder cancer	8.92e-05	0.000468	CcSEcCtD
Desmopressin—Headache—Epirubicin—urinary bladder cancer	8.88e-05	0.000466	CcSEcCtD
Desmopressin—Dizziness—Doxorubicin—urinary bladder cancer	8.67e-05	0.000455	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—CXCL8—urinary bladder cancer	8.6e-05	0.00212	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—CXCL8—urinary bladder cancer	8.54e-05	0.0021	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	8.43e-05	0.00208	CbGpPWpGaD
Desmopressin—Nausea—Epirubicin—urinary bladder cancer	8.42e-05	0.000442	CcSEcCtD
Desmopressin—Vomiting—Doxorubicin—urinary bladder cancer	8.34e-05	0.000437	CcSEcCtD
Desmopressin—AVPR2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.33e-05	0.00205	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	8.28e-05	0.00204	CbGpPWpGaD
Desmopressin—Rash—Doxorubicin—urinary bladder cancer	8.27e-05	0.000434	CcSEcCtD
Desmopressin—Dermatitis—Doxorubicin—urinary bladder cancer	8.26e-05	0.000433	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	8.25e-05	0.00203	CbGpPWpGaD
Desmopressin—Headache—Doxorubicin—urinary bladder cancer	8.21e-05	0.000431	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	8.2e-05	0.00202	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	8.04e-05	0.00198	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—RHOA—urinary bladder cancer	7.99e-05	0.00197	CbGpPWpGaD
Desmopressin—Nausea—Doxorubicin—urinary bladder cancer	7.79e-05	0.000409	CcSEcCtD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	7.78e-05	0.00192	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—S100B—urinary bladder cancer	7.65e-05	0.00188	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	7.49e-05	0.00184	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	7.47e-05	0.00184	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	7.4e-05	0.00182	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.34e-05	0.00181	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RBX1—urinary bladder cancer	7.32e-05	0.0018	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.29e-05	0.0018	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RBX1—urinary bladder cancer	7.27e-05	0.00179	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—RHOA—urinary bladder cancer	7.26e-05	0.00179	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTO2—urinary bladder cancer	7.09e-05	0.00174	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NAT1—urinary bladder cancer	7.09e-05	0.00174	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—CXCL8—urinary bladder cancer	7.02e-05	0.00173	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.97e-05	0.00172	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TSC1—urinary bladder cancer	6.88e-05	0.00169	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NCOR1—urinary bladder cancer	6.88e-05	0.00169	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TSC1—urinary bladder cancer	6.83e-05	0.00168	CbGpPWpGaD
Desmopressin—PTGS2—Disease—GSTO2—urinary bladder cancer	6.72e-05	0.00165	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR downstream signaling—IL2—urinary bladder cancer	6.7e-05	0.00165	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	6.58e-05	0.00162	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—JAG1—urinary bladder cancer	6.55e-05	0.00161	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—JAG1—urinary bladder cancer	6.51e-05	0.0016	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.48e-05	0.0016	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	6.48e-05	0.0016	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.46e-05	0.00159	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	6.45e-05	0.00159	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.43e-05	0.00158	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—CXCL8—urinary bladder cancer	6.37e-05	0.00157	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	6.29e-05	0.00155	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	6.13e-05	0.00151	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—IL2—urinary bladder cancer	6.09e-05	0.0015	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TERT—urinary bladder cancer	6.07e-05	0.00149	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.96e-05	0.00147	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.95e-05	0.00146	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.93e-05	0.00146	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	5.83e-05	0.00144	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	5.79e-05	0.00143	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.64e-05	0.00139	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTO2—urinary bladder cancer	5.62e-05	0.00138	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NAT1—urinary bladder cancer	5.62e-05	0.00138	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—FGFR3—urinary bladder cancer	5.57e-05	0.00137	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.56e-05	0.00137	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—RHOA—urinary bladder cancer	5.54e-05	0.00136	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.53e-05	0.00136	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	5.51e-05	0.00136	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—RHOA—urinary bladder cancer	5.5e-05	0.00135	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ESR1—urinary bladder cancer	5.41e-05	0.00133	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PRSS3—urinary bladder cancer	5.37e-05	0.00132	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—S100B—urinary bladder cancer	5.31e-05	0.00131	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—S100B—urinary bladder cancer	5.27e-05	0.0013	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SLC19A1—urinary bladder cancer	5.22e-05	0.00129	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	5.14e-05	0.00127	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PRSS3—urinary bladder cancer	5.09e-05	0.00125	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	5.07e-05	0.00125	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—RHOA—urinary bladder cancer	5.03e-05	0.00124	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—RHOA—urinary bladder cancer	4.99e-05	0.00123	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.92e-05	0.00121	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.86e-05	0.0012	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HDAC4—urinary bladder cancer	4.86e-05	0.0012	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—CXCL8—urinary bladder cancer	4.83e-05	0.00119	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.81e-05	0.00118	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NCOR1—urinary bladder cancer	4.77e-05	0.00117	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CREBBP—urinary bladder cancer	4.74e-05	0.00117	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NCOR1—urinary bladder cancer	4.74e-05	0.00117	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.72e-05	0.00116	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IGF1—urinary bladder cancer	4.68e-05	0.00115	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—EGFR—urinary bladder cancer	4.66e-05	0.00115	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR downstream signaling—IL2—urinary bladder cancer	4.65e-05	0.00114	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	4.63e-05	0.00114	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—IL2—urinary bladder cancer	4.61e-05	0.00114	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	4.58e-05	0.00113	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—CXCL8—urinary bladder cancer	4.42e-05	0.00109	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—KRAS—urinary bladder cancer	4.4e-05	0.00108	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—CXCL8—urinary bladder cancer	4.38e-05	0.00108	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	4.37e-05	0.00108	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.31e-05	0.00106	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TYMP—urinary bladder cancer	4.29e-05	0.00106	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—RHOA—urinary bladder cancer	4.29e-05	0.00106	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PRSS3—urinary bladder cancer	4.26e-05	0.00105	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL2—urinary bladder cancer	4.22e-05	0.00104	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TERT—urinary bladder cancer	4.2e-05	0.00103	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL2—urinary bladder cancer	4.19e-05	0.00103	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TERT—urinary bladder cancer	4.17e-05	0.00103	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.17e-05	0.00103	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.12e-05	0.00101	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	4.04e-05	0.000994	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.03e-05	0.000993	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.02e-05	0.00099	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—ERBB2—urinary bladder cancer	3.97e-05	0.000977	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.88e-05	0.000956	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FGFR3—urinary bladder cancer	3.86e-05	0.00095	CbGpPWpGaD
Desmopressin—PTGS2—Disease—LIG1—urinary bladder cancer	3.86e-05	0.000949	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.84e-05	0.000945	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FGFR3—urinary bladder cancer	3.83e-05	0.000943	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CXCL8—urinary bladder cancer	3.76e-05	0.000926	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ESR1—urinary bladder cancer	3.75e-05	0.000922	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—HRAS—urinary bladder cancer	3.74e-05	0.00092	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.73e-05	0.000919	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ESR1—urinary bladder cancer	3.72e-05	0.000916	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL2—urinary bladder cancer	3.6e-05	0.000885	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CCND1—urinary bladder cancer	3.51e-05	0.000863	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.42e-05	0.000841	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TYMP—urinary bladder cancer	3.41e-05	0.000839	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MMP9—urinary bladder cancer	3.4e-05	0.000838	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.39e-05	0.000835	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PTEN—urinary bladder cancer	3.38e-05	0.000833	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.35e-05	0.000825	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.34e-05	0.000823	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CREBBP—urinary bladder cancer	3.28e-05	0.000808	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.27e-05	0.000806	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.27e-05	0.000805	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CREBBP—urinary bladder cancer	3.26e-05	0.000803	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IGF1—urinary bladder cancer	3.24e-05	0.000798	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—EGFR—urinary bladder cancer	3.23e-05	0.000794	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EP300—urinary bladder cancer	3.23e-05	0.000794	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IGF1—urinary bladder cancer	3.22e-05	0.000793	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—EGFR—urinary bladder cancer	3.2e-05	0.000789	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SRC—urinary bladder cancer	3.14e-05	0.000772	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.12e-05	0.000767	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.1e-05	0.000764	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.1e-05	0.000764	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.09e-05	0.000761	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.09e-05	0.000759	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NAT2—urinary bladder cancer	3.08e-05	0.000759	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—KRAS—urinary bladder cancer	3.05e-05	0.00075	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KRAS—urinary bladder cancer	3.03e-05	0.000745	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.01e-05	0.000741	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RHOA—urinary bladder cancer	2.97e-05	0.000731	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.96e-05	0.00073	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RHOA—urinary bladder cancer	2.95e-05	0.000726	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO2—urinary bladder cancer	2.94e-05	0.000724	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—MYC—urinary bladder cancer	2.81e-05	0.000692	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RBX1—urinary bladder cancer	2.79e-05	0.000686	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—ERBB2—urinary bladder cancer	2.75e-05	0.000677	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—EGFR—urinary bladder cancer	2.75e-05	0.000677	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.75e-05	0.000676	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—ERBB2—urinary bladder cancer	2.73e-05	0.000672	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.66e-05	0.000655	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CXCL8—urinary bladder cancer	2.61e-05	0.000642	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—urinary bladder cancer	2.6e-05	0.00064	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—urinary bladder cancer	2.59e-05	0.000638	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CXCL8—urinary bladder cancer	2.59e-05	0.000637	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—urinary bladder cancer	2.57e-05	0.000633	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.5e-05	0.000616	CbGpPWpGaD
Desmopressin—PTGS2—Disease—JAG1—urinary bladder cancer	2.5e-05	0.000614	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL2—urinary bladder cancer	2.49e-05	0.000614	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL2—urinary bladder cancer	2.47e-05	0.000609	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.46e-05	0.000606	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.46e-05	0.000606	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.45e-05	0.000603	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CCND1—urinary bladder cancer	2.43e-05	0.000598	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.43e-05	0.000597	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CCND1—urinary bladder cancer	2.41e-05	0.000594	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.39e-05	0.000588	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MMP9—urinary bladder cancer	2.36e-05	0.000581	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.35e-05	0.000579	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.35e-05	0.000579	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTEN—urinary bladder cancer	2.35e-05	0.000577	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MMP9—urinary bladder cancer	2.34e-05	0.000577	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—CDKN1A—urinary bladder cancer	2.33e-05	0.000574	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTEN—urinary bladder cancer	2.33e-05	0.000573	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—urinary bladder cancer	2.31e-05	0.000568	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EP300—urinary bladder cancer	2.24e-05	0.000551	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EP300—urinary bladder cancer	2.22e-05	0.000547	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—urinary bladder cancer	2.21e-05	0.000544	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SRC—urinary bladder cancer	2.18e-05	0.000535	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SRC—urinary bladder cancer	2.16e-05	0.000532	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.12e-05	0.000521	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.09e-05	0.000514	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.02e-05	0.000497	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.99e-05	0.000489	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—MYC—urinary bladder cancer	1.95e-05	0.00048	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.94e-05	0.000477	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MYC—urinary bladder cancer	1.94e-05	0.000476	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.92e-05	0.000472	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.92e-05	0.000472	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—EGFR—urinary bladder cancer	1.91e-05	0.000469	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—EGFR—urinary bladder cancer	1.89e-05	0.000466	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.84e-05	0.000452	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NCOR1—urinary bladder cancer	1.82e-05	0.000447	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.8e-05	0.000444	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—urinary bladder cancer	1.8e-05	0.000443	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—urinary bladder cancer	1.79e-05	0.00044	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERCC2—urinary bladder cancer	1.71e-05	0.000421	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.69e-05	0.000417	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.68e-05	0.000414	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.66e-05	0.000408	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MTHFR—urinary bladder cancer	1.61e-05	0.000395	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.6e-05	0.000394	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TERT—urinary bladder cancer	1.6e-05	0.000394	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—urinary bladder cancer	1.6e-05	0.000394	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—urinary bladder cancer	1.59e-05	0.000391	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.54e-05	0.000379	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—urinary bladder cancer	1.53e-05	0.000377	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.52e-05	0.000375	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.52e-05	0.000375	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—urinary bladder cancer	1.52e-05	0.000374	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FGFR3—urinary bladder cancer	1.47e-05	0.000362	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.46e-05	0.000359	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.43e-05	0.000352	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.37e-05	0.000338	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.35e-05	0.000331	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.32e-05	0.000325	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CREBBP—urinary bladder cancer	1.25e-05	0.000308	CbGpPWpGaD
Desmopressin—PTGS2—Disease—RHOA—urinary bladder cancer	1.13e-05	0.000279	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PPARG—urinary bladder cancer	1.09e-05	0.000268	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.08e-05	0.000266	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CREBBP—urinary bladder cancer	1.05e-05	0.000258	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERBB2—urinary bladder cancer	1.05e-05	0.000258	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTEN—urinary bladder cancer	9.43e-06	0.000232	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—EP300—urinary bladder cancer	8.99e-06	0.000221	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CDKN1A—urinary bladder cancer	8.96e-06	0.00022	CbGpPWpGaD
Desmopressin—PTGS2—Disease—PTEN—urinary bladder cancer	8.94e-06	0.00022	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EP300—urinary bladder cancer	8.52e-06	0.00021	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SRC—urinary bladder cancer	8.29e-06	0.000204	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PTEN—urinary bladder cancer	7.48e-06	0.000184	CbGpPWpGaD
Desmopressin—PTGS2—Disease—MYC—urinary bladder cancer	7.43e-06	0.000183	CbGpPWpGaD
Desmopressin—PTGS2—Disease—EGFR—urinary bladder cancer	7.26e-06	0.000179	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—EP300—urinary bladder cancer	7.14e-06	0.000176	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—urinary bladder cancer	6.86e-06	0.000169	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—urinary bladder cancer	5.83e-06	0.000144	CbGpPWpGaD
